Franco Poletti - 11 Mar 2026 Form 4 Insider Report for LivaNova PLC (LIVN)

Role
President, Cardiopulmonary
Signature
/s/ Sarah K. Mohr, Attorney-in-Fact
Issuer symbol
LIVN
Transactions as of
11 Mar 2026
Net transactions value
$0
Form type
4
Filing time
13 Mar 2026, 17:25:31 UTC
Previous filing
17 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Poletti Franco President, Cardiopulmonary 20 EASTBOURNE TERRACE, LONDON, UNITED KINGDOM /s/ Sarah K. Mohr, Attorney-in-Fact 13 Mar 2026 0002031281

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIVN Ordinary Shares Options Exercise +2,140 +24% $57.60* 10,990 11 Mar 2026 Direct
transaction LIVN Ordinary Shares Tax liability -1,980 -18% $62.26* 9,010 11 Mar 2026 Direct F1
transaction LIVN Ordinary Shares Tax liability -69 -0.77% $62.26* 8,941 11 Mar 2026 Direct F2
holding LIVN Ordinary Shares 219 11 Mar 2026 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIVN Stock Appreciation Rights Options Exercise -2,140 -100% $0.000000* 0 11 Mar 2026 Ordinary Shares 2,140 $57.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for stock appreciation right ("SAR") base price settlement.
F2 Shares withheld to satisfy tax liability.
F3 Reporting person was granted SARs on March 11, 2016 that vested in four equal annual installments beginning March 11, 2017 under the LivaNova PLC 2015 Incentive Award Plan and were automatically exercised upon their March 11, 2026 expiration date.